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In a contribution to this Research Topic Erkki Somersalo and Daniela Calvetti carried out
a mathematical analysis of neurotransmitter pathways in brain, modeling compartmental
nitrogen flux among several major participants – ammonia, glutamine, glutamate, GABA,
and selected amino acids.This analysis is important because cerebral nitrogen metabolism
is perturbed in many diseases, including liver disease and inborn errors of the urea cycle.
These diseases result in an elevation of blood ammonia, which is neurotoxic. Here, a brief
description is provided of the discovery of cerebral metabolic compartmentation of nitrogen metabolism – a key feature of cerebral glutamate–glutamine and GABA–glutamine
cycles. The work of Somersalo and Calvetti is discussed as a model for future studies of
normal and pathological cerebral ammonia metabolism.
Keywords: branched-chain amino acid branched-chain keto acid shuttle, GABA–glutamine cycle, glutamate–
glutamine cycle, metabolic compartmentation, cerebral nitrogen metabolism

The concept of compartmentation of cerebral nitrogen metabolism originated with the classic work of Berl et al. (1). These
authors infused large (non-tracer) doses of [15 N]ammonia into
cats and determined the relative enrichment of 15 N in cerebral
glutamate, glutamine (amine), and glutamine (amide). Glutamine
synthetase (GS) catalyzes the conversion of ammonia and glutamate to glutamine (Eq. 1). A portion of this glutamate was
labeled with 15 N as a result of the action of glutamate dehydrogenase (GDH) (Eq. 2). Thus, if the brain were acting as a
single metabolic compartment, the relative enrichment of label
should have been greater in glutamate precursor than in glutamine (amine). However, the relative enrichment of 15 N was found
to be: glutamine (amide) > glutamine (amine) > glutamate. This
finding prompted Berl et al. (1) to suggest that in the brain, glutamate is rapidly turned over to glutamine in a small compartment
that is distinct from a larger compartment of more slowly turning over glutamate. We later verified cerebral compartmentation
using intracarotid and intraventricular infusion of tracer quantities of [13 N]ammonia into rats (2). Importantly, Norenberg and
colleagues showed that in brain parenchyma GS is present exclusively in astrocytes (3, 4). [See also the article in this Research
Topic by Derouiche and Anlauf.] Thus, ammonia entering the
brain largely by diffusion of ammonia free base (NH3 ) (2, 5, 6) is
rapidly converted to glutamine (amide) in the small compartment
(i.e., astrocytes). The large compartment approximately represents
the neurons, which contain a portion of the GDH activity of the
brain.
L-Glutamate + NH3 + ATP  L-glutamine + ADP + Pi
α-Ketoglutarate

+ NH+
4

+

+ NAD(P) + H2 O

(1)

+ NAD(P)H  L-glutamate
(2)

Compartmentation plays a pivotal role in the cerebral
glutamate–glutamine cycle. Thus, glutamate released during
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neurotransmission is taken up in the small compartment (astrocytes), where it is converted to glutamine by GS. Glutamine is
released from the astrocytes to the large compartment (neurons)
where it is hydrolyzed by glutaminase (phosphate-activated glutaminase; PAG; Eq. 3) to glutamate and ammonia, completing the
cycle (7, 8).
L-Glutamine + H2 O → L-glutamate + NH3

(3)

The glutamate–glutamine cycle is not strictly stoichiometric
and is “leaky.” For example, net uptake of many amino acids
occurs across the human blood–brain barrier (BBB) (9). The nitrogen obtained from this source contributes to the astrocytic pool
of nitrogen in glutamate and glutamine. Moreover, not all astrocytic glutamine is released to the neurons. To maintain nitrogen
balance cerebral glutamine is released to the extracellular fluids
and circulation (10). Nevertheless, the concept of a glutamate–
glutamine cycle has been useful in furthering our understanding
of nitrogen homeostasis in the brain. The flux through this cycle
is extremely rapid, estimated to be about 80% the rate of glucose
oxidation (11).
[13 N]Ammonia has proved useful in positron-emission tomography (PET) studies of cerebral ammonia metabolism in controls,
cirrhotics with non-overt encephalopathy, and cirrhotics with
overt encephalopathy (12, 13). The main finding is that cerebral ammonia metabolism is enhanced due to increased blood
ammonia in cirrhotic patients, but the kinetics of cerebral ammonia uptake and metabolism are not affected by hyperammonemia.
Thus, owing to the higher concentration of ammonia in the blood,
more ammonia will enter the brain in hyperammonemic patients
than in normoammonemic individuals, despite the fact that tracer
uptake by the brain is similar in the two groups. Because metabolic
trapping of [13 N]ammonia is similar in both cases, the findings
suggest that the concentration of ammonia in astrocytes is below

November 2013 | Volume 4 | Article 179 | 1

Cooper

the K m value exhibited by GS toward ammonia even in the hyperammonemic individuals. In this regard, the whole brain ammonia
concentration in the rat is estimated to be ∼180 µM (10), a value
identical to the K m for ammonia exhibited by ovine brain GS
(14). Moreover, as discussed below, the ammonia concentration
in astrocytes is likely to be even lower than that of intact brain.
Some evidence suggests that the specific activity of cerebral GS
is decreased in portacaval-shunted rats (a model of chronic liver
disease) (15, 16). Nevertheless, increased influx of ammonia in
hyperammonemic individuals will result in increased synthesis
of astrocytic glutamine. Owing to the uncertainty of the specific
activity of [13 N]ammonia in the astrocytes it is not yet possible to
assign an absolute value for glutamine synthesis in the brains of
normal and cirrhotic patients using PET. Nevertheless, the trapping of blood-derived [13 N]ammonia in human brain is consistent
with a rapid nitrogen flow through the glutamate–glutamine cycle.
A GABA–glutamine cycle also operates in the brain. Inhibitory
neurotransmitter GABA released by neurons is taken up in part by
astrocytes. In the astrocytes, GABA is transaminated to succinic
semialdehyde, which is oxidized to succinate by succinic semialdehyde dehydrogenase, allowing the 4-carbon unit of GABA
to enter the tricarboxylic acid (TCA) cycle (the GABA shunt).
Glutamine is then released to the neurons and converted to glutamate. A portion of this glutamate is decarboxylated to GABA,
thereby completing the GABA–glutamine cycle (17, 18). In the
brain, acetate is metabolized exclusively in astrocytes (19). Studies
with [13 C]acetate suggest that flux through the GABA–glutamine
cycle in the neocortex of vigabatrin-treated rats is about 6% the
rate through the TCA cycle (20). In a more recent study, van Eijsden et al. (21) calculated the flux through the glutamate–glutamine
cycle, GABA–glutamine cycle, and GABA shunt in rat brain to
be 0.274 ± 0.023, 0.033 ± 0.005, and 0.025 ± 0.006 µmol/min/g,
respectively.
Most of the ammonia destined for glutamine (amide) synthesis in astrocytes is likely derived from ammonia taken up
from the blood/cerebrospinal fluid (CSF) and from ammoniagenerating reactions in both astrocytes and neurons. But how is
the astrocytic glutamate (amine) pool maintained? In the simplest explanation, glutamate released from the neurons is stoichiometrically converted to glutamine in the astrocytes, but this
is unlikely. Despite the fact that the GDH reaction is reversible
(accounting for labeling of brain glutamate in tracer studies with
[13 N]ammonia/[15 N]ammonia) it is likely that the net direction
of the GDH reaction in astrocytes (22) and in whole brain is in
the direction of glutamate oxidation (23). Thus, α-ketoglutarate
generated by the GDH reaction in astrocytes must be converted back to glutamate to maintain glutamate balance (24, 25).
This conversion can be accomplished by transamination of αketoglutarate. However, in order to maintain nitrogen homeostasis
the amino acid transamination partner must be imported into
astrocytes from the neurons or from the blood/CSF. As discussed
below, various neuron-to-astrocyte amino acid shuttles have been
proposed.
Waagepetersen and colleagues (26–29) suggested that ammonia
is incorporated into glutamate in neurons via the GDH reaction
(forward direction of Eq. 2) and thence into alanine by means of
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the alanine aminotransferase (ALAT)-catalyzed reaction (Eq. 4).
Alanine is then transported into the astrocytes and transaminated
with α-ketoglutarate to regenerate glutamate nitrogen (Eq. 5). In
support of this notion both glutamine and alanine are greatly elevated in cerebral extracellular fluid in hyperammonemic patients
with fulminant hepatic failure (30) and in a rat model of this disease (31). Carbon balance may possibly be maintained by transfer
of lactate from astrocytes to neurons (the lactate–alanine cycle).
Redox balance is maintained because GDH is proposed to catalyze
net reductive amination of α-ketoglutarate in neurons (Eq. 2, forward reaction) and net oxidation of glutamate in astrocytes (Eq.
2; back reaction). However, tracer studies with 15 N-labeled alanine, ammonia, and glutamine revealed no direct coupling of the
glutamate–glutamine and lactate–alanine shuttles in cerebellar cocultures (27). Moreover, the existence of an astrocyte-to-neuron
lactate shuttle is controversial (32). Therefore, the following discussion will focus only on the part of the pathway suggested to
transfer alanine nitrogen from neurons to astrocytes, which is
referred to as the alanine shuttle.
Previous work has shown that (1) the specific activity of
cerebral ALAT is relatively low (33), (2) even after a 20min intracarotid infusion of [13 N]ammonia into the rat brain,
label cannot be detected in alanine despite labeling of glutamate (23), and (3) even after brain GS is inhibited 85% by
the GS inhibitor l-methionine-S,R-sulfoximine (MSO) and the
rats are hyperammonemic, relatively little label derived from
intracarotid [13 N]ammonia is incorporated into brain glutamate
(2, 23). Thus, under normoammonemic conditions an alanine
shuttle [i.e., ammonia → glutamate (neurons) → alanine (neurons) → alanine (astrocytes) → glutamate (astrocytes)] is likely
to be of minor importance for replenishing glutamate nitrogen
in astrocytes (23). Bak et al. (27), however, suggest that the alanine
shuttle may be prominent under hyperammonemic conditions.
Pyruvate + L-glutamate → L-alanine
+ α-ketoglutarate (neurons)

(4)

L-Alanine + α-ketoglutarate → pyruvate
+ L-glutamate (astrocytes)

(5)

Another nitrogen shuttle is the branched-chain amino
acid/branched-chain α-keto acid (BCAA/BCKA) shuttle, first proposed by Hutson et al. (34, 35). These authors pointed out
the unique distribution of the branched-chain aminotransferase
(BCAT) isozymes in brain. The cytosolic isozyme (BCATc) is
widely distributed in tissues, including brain, whereas the mitochondrial isozyme (BCATm) is confined to brain, placenta, and
ovaries (34). In the brain, BCATc is more prevalent in neurons,
whereas BCATm is more prevalent in the astrocytes (34). The presence of both BCAT isozymes in the brain suggests that they play
an important role in maintaining cerebral BCAA homeostasis (34,
35). In the BCAA/BCKA shuttle, BCATc catalyzes the transamination of a BCKA, such as α-ketoisocaproate (KIC, the α-keto acid
analog of leucine) with glutamate in neurons (Eq. 6). The resulting
BCAA is taken up by astrocytes, where BCATm catalyzes the transfer of nitrogen from the BCAA to α-ketoglutarate, regenerating
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glutamate (Eq. 7). The KIC generated in the astrocytes is returned
to the neurons conserving carbon balance.
L-Glutamate + α-ketoisocaproate → α-ketoglutarate
+ L-leucine (neurons)

(6)

L-Leucine + α-ketoglutarate → α-ketoisocaproate
+ L-glutamate (astrocytes)

(7)

The notion that astrocytes metabolize leucine has strong support. Leucine is taken up across the human BBB (9) and has a
relatively high brain uptake index in rats (36). Moreover, Berl and
Frigyesi (37, 38) previously showed that leucine is metabolized
in the small compartment in cat brain. As pointed out by Yudkoff et al. (39, 40), transfer of leucine nitrogen to α-ketoglutarate
is favorable in brain, especially in astrocytes. Isoleucine, another
BCAA, is of interest because its metabolism will not only replenish glutamate nitrogen in astrocytes, but also generate the TCA
cycle intermediates succinyl-CoA and acetyl-CoA (41). However,
although isoleucine provides some cerebral glutamate nitrogen
this contribution is likely modest (41). Nevertheless, an analysis
by Rothman et al. (25) suggests that the BCAA/BKCAA shuttle in
brain is feasible. But, as pointed out by Somersalo and Calvetti
(42) the proposed BCAA/BCKA shuttle is problematic because
the GDH reaction is suggested to proceed in the direction of
reductive amination of α-ketoglutarate in the neurons and oxidation of glutamate in the astrocytes. As noted above, relatively
little label derived from intracarotid [13 N]ammonia is incorporated into brain glutamate in MSO-treated rats even when GS
is inhibited 85% and the animals are hyperammonemic. Under
these conditions, compartmentalization of ammonia metabolism
in the brain is disrupted such that blood-derived [13 N]ammonia,
which would normally have been efficiently trapped as glutamine
(amide) in astrocytes, freely mixes with the neuronal ammonia
pool. If the GDH reaction were important for the net synthesis of
glutamate in neurons considerable label should have been present
in brain glutamate in the MSO-treated rats. The fact that this was
not observed suggests that the GDH reaction is not important
for the net synthesis of glutamate in neurons even under hyperammonemic conditions. Thus, although transfer of leucine and
other BCAAs between neurons and astrocytes is feasible and much
evidence suggests that leucine is transaminated in astrocytes, the
GDH reaction is unlikely to play a major role in any BCAA/BCKA
shuttle.
As the above discussion attests, glutamate/glutamine homeostasis in astrocytes is still not fully understood. Somersalo and
Calvetti (42) offer a mechanism for balancing nitrogen and carbon
metabolism in the brain by suggesting that alanine derived from
transamination of pyruvate with glutamate in the neurons (Eq.
4) is taken up by astrocytes, where the reverse reaction transfers
the amino group from alanine to α-ketoglutarate (Eq. 5). Concomitantly, α-ketoglutarate is transaminated with leucine in the
neurons to generate glutamate and KIC by the action of BCATc.
This KIC is taken up by the astrocytes where it is transaminated
with glutamate to generate leucine and α-ketoglutarate via a reaction catalyzed by BCATm. [The direction of nitrogen flow is the
opposite of that shown in Eqs 6 and 7.] According to their Fig. 10
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the combined action of the alanine shuttle and the GDH reaction
replenishes the ammonia pool in the astrocytes.
The Somersalo and Calvetti model will be useful for further
studies of cerebral nitrogen metabolism. The results of our 13 N
tracer studies suggest that nitrogen shuttles requiring operation
of the GDH reaction in opposite directions in astrocytes and
neurons are unlikely. In the model suggested by Somersalo and
Calvetti the GDH reaction proceeds in the direction of oxidative
deamination of glutamate in both compartments in agreement
with our previous findings (see their Fig 10). The Somersalo
and Calvetti model also requires a net movement of ammonia
from neurons to astrocytes, consistent with our results obtained
with [13 N]ammonia. A major source of ammonia in the neurons is the PAG reaction. However, there are many additional
enzyme-catalyzed metabolic reactions that can generate ammonia
in both compartments, including the GDH reaction (10). Tracer
studies with blood-derived [13 N]ammonia clearly show that the
two metabolic pools of ammonia in the rat brain do not readily mix except under hyperammonemic conditions in which the
GS reaction is strongly inhibited (2). Despite the presence of two
kinetically distinct ammonia compartments in the normal brain
the ammonia generated in the neuronal compartment must be
disposed of eventually. Since the GDH reaction in neurons is
unlikely to participate in the net removal of ammonia and the
brain does not have a complete urea cycle, the overwhelming route
for removal of neuron-derived ammonia is the GS reaction in
astrocytes. Evidently, under normoammonemic conditions the GS
reaction removes ammonia efficiently from the astrocyte pool at a
rate that ensures a net movement/gradient of ammonia from neurons to astrocytes, preventing uniform mixing of ammonia in the
small and large compartments. In this regard, previous work has
shown that ammonia is passively and actively rapidly transported
into astrocytes in culture (43).
An unresolved issue is the nature of the transamination partners required for net conversion of α-ketoglutarate to glutamate in
astrocytes. As noted above, neuronal-derived alanine is a possible
source (42), but the contribution of alanine may be quantitatively
minor under normoammonemic conditions. Another possibility is neuron-derived aspartate (Eqs 8 and 9) as suggested by
Pardo et al. (24). In many respects, aspartate is a more attractive
transamination partner in astrocytes than is alanine as a source
of glutamate nitrogen. Aspartate aminotransferase (ASPAT) is
extremely active in most tissues and the components of the reaction are thought to be at or near thermodynamic equilibrium in
brain (44, 45) and liver (46). As a result, nitrogen is exchanged
extremely rapidly between glutamate and aspartate in these tissues (23, 45, 47). Moreover, ASPAT is present in cytosolic and
mitochondrial compartments. Thus, any model of nitrogen flux
among amino acids that are transaminated with α-ketoglutarate
in the brain must take into account nitrogen exchange between
glutamate and aspartate in mitochondria and cytosol. A variant
of the model proposed by Pardo et al. (24) has been suggested by
Hertz (48). In the Hertz model ASPAT-catalyzed transamination
of aspartate with α-ketoglutarate in astrocyte cytosol is retained.
However, the “missing” aspartate is generated in the astrocytic
mitochondria by transamination of glutamate with oxaloacetate
rather than from the mitochondrial ASPAT reaction in neurons as
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envisaged by Pardo et al. (24).
L-Glutamate + oxaloacetate → α-ketoglutarate
+ L-aspartate (neurons)

(8)

L-Aspartate + α-ketoglutarate → oxaloacetate
+ L-glutanate (astrocytes)

(9)

Finally, the importance of linked aminotransferase reactions
in the brain should be emphasized. The capacity of the brain to
catalyze α-ketoglutarate- and glutamate-linked aminotransferase
reactions with a large number of amino acids/α-keto acids is considerable (33). As noted above, the brain has the capacity to take up
many amino acids from the circulation, including BCAAs. These
amino acids can then contribute to the astrocytic pool of glutamate
nitrogen via α-ketoglutarate-linked aminotransferase reactions.

FIGURE 1 | Major routes for nitrogen homeostasis in the brain with
emphasis on the central importance of ammonia. Abbreviations: AA,
amino acid; αKA, α-keto acid; αKG, α-ketoglutarate; A–V, arterial–venous; BBB,
blood–brain barrier; CSF, cerebrospinal fluid; GDH, glutamate dehydrogenase;
GS, glutamine synthetase; PAG, phosphate-activated glutaminase; PC,
pyruvate carboxylase. Enzyme reactions: (1) GS, (2) PAG, (3) GDH, (4) various
αKG/glutamate-linked aminotransferases. Tracer studies with [13 N]ammonia
have shown that about 25–40% of the tracer is taken up in a single pass
through the brain (2, 5, 6). Most of this blood-derived [13 N]ammonia (as well
as CSF-derived [13 N]ammonia) is rapidly trapped in the astrocyte compartment
as L-[amide-13 N]glutamine by the action of GS. The cerebral trapping of
blood-derived [13 N]ammonia suggests that there should be an A–V difference
for ammonia across normal brain. However, the concentration of ammonia in
blood is relatively low (<40 µM in normal human blood and <80 µM in normal
rat blood). As a result, a cerebral A–V difference for ammonia is difficult to
measure in normoammonemia, although it is well documented to occur
during hyperammonemia [reviewed by (10)]. A net cerebral uptake of many
AAs has been demonstrated for healthy human volunteers in the post
absorptive state (9). In order to maintain cerebral nitrogen balance some
glutamine is released to the blood/CSF, a process that is more pronounced
during hyperammonemia [reviewed by (10)]. As a result, the concentration of
glutamine in the normal CSF/extracerebral fluid is relatively high and much
higher than that of any other amino acid (49). Many endogenous reactions
contribute to the cerebral ammonia metabolic pool, but especially the PAG
and GDH reactions (10). As a result of rapid removal of this ammonia as
glutamine there is an ammonia concentration gradient from the neurons to
+
the astrocytes, maintained by diffusion of NH3 and active transport of NH4
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A diagram of the major pathways contributing to cerebral
nitrogen homeostasis is shown in Figure 1. Summary: (1) Ammonia for glutamine synthesis in astrocytes is obtained by diffusion from blood and CSF, and from numerous endogenous
enzyme-catalyzed reactions, but principally the PAG reaction (in
neurons) and the GDH reaction (in both astrocytes and neurons). (2) To maintain nitrogen balance glutamine is exported
to blood/CSF. (3) The net GDH-catalyzed conversion of glutamate to α-ketoglutarate and ammonia in astrocytes results in a
drain on glutamate in these cells that cannot be replenished by the
glutamate–glutamine cycle (or GABA–glutamine cycle). (4) Conversion of α-ketoglutarate back to glutamate in astrocytes can be
accomplished by α-ketoglutarate-linked aminotransferases, which
are well represented in brain. (5) Transamination partners in the
astrocytes include neuron-derived alanine (less important) and
aspartate (more important). (6) ASPAT is crucial in maintaining

[c.f. (43)]. During the glutamate–glutamine cycle, approximately one
equivalent of nitrogen enters the astrocytes as glutamate and approximately
two equivalents exit as glutamine. One equivalent of nitrogen in glutamine is
readily obtained from ammonia, which is incorporated into the amide position.
The other nitrogen in glutamine is derived from glutamate. However, a portion
of this glutamate is metabolized to αKG and ammonia by the action of GDH.
Moreover, some carbon/nitrogen originating in glutamate is lost when
glutamine exits the brain. Glutamate carbon may be replenished in astrocytes
by anaplerotic mechanisms, most notably pyruvate carboxylase (PC). [PC
activity is present exclusively in astrocytes, and its activity has been
estimated to be about 37% that of the cerebral glutamine synthesis rate (50).]
Glutamate nitrogen is replenished in the astrocyte by transamination
reactions between αKG and a suitable AA, generating the corresponding αKA.
Leucine is an especially favorable aminotransferase partner in astrocytes,
because (1) it is readily taken up across the BBB (9), (2) blood-derived leucine
is metabolized in the small compartment (i.e., astrocytes) (37, 38), and (3)
both astrocytes and neurons contain appreciable branched-chain amino acid
aminotransferase activity (34, 35). Another possible aminotransferase partner
in the astrocytes is aspartate (24, 48). Note: (1) for simplicity, the
GABA–glutamine cycle is not shown as it is considerably slower than the
glutamate–glutamine cycle; (2) endogenously generated ammonia is depicted
+
as NH3 (but represents NH3 + NH4 ); (3) enzyme cofactors are not shown; (4)
tracer studies show that the cerebral GDH reaction is reversible, but as
discussed in the text the net direction of the GDH reaction in both astrocytes
and neurons is likely in the direction of glutamate oxidation to αKG and
ammonia; and (5) possible movements of αKAs between neurons and
astrocytes (required for carbon balance) are not shown.

November 2013 | Volume 4 | Article 179 | 4

Cooper

cerebral nitrogen balance. (7) Additional transaminase partners in
the astrocytes include amino acids taken up across the BBB, most
notably the BCAAs. Evidently, much work remains in elucidating
mechanisms contributing to cerebral nitrogen flux/homeostasis.
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